Objective The aim of our study was to explore a possible relationship between proportion of
basal insulin dose (% BD/T) and glycaemic control in children with type I diabetes on …

Objective: To assess the contribution of basal insulin to the total daily dose (CBITDD) and to
identify the determinant factors in children with type 1 diabetes mellitus. Study design: Cross …

OBJECTIVE: To examine the effect of continuous subcutaneous insulin infusion (CSII)
therapy on parameters affecting long-term outcome in type 1 diabetes. STUDY DESIGN …

Aims To determine the safety and effectiveness of continuous subcutaneous insulin infusion
(CSII) in attaining long‐term glycaemic control in paediatric patients with Type 1 diabetes …

Aim To evaluate the efficacy and safety of continuous subcutaneous insulin infusion (CSII),
and its impact on glycaemic control, insulin doses and auxological parameters in children …

Aims: Identifying age‐dependent basal rates in type 1 diabetic children treated with
continuous subcutaneous insulin infusion (CSII). Methods: CSII‐treated children with type 1 …

Abstract Treatment with continuous subcutaneous insulin infusion (CSII) allows a large
degree of treatment individualization and intensification in children with diabetes. The …

Objective. The purpose of this study was to determine the feasibility of continuous
subcutaneous insulin infusion (CSII)(insulin pump) therapy in routine pediatric diabetes care …

Objective: The aim of this study was to investigate the safety and efficacy of continuous
subcutaneous insulin infusion (CSII) for type 1 diabetes mellitus (T1DM) in toddlers and …

Aims To conduct a multicentre, matched‐pair cohort analysis comparing glycaemic control
and adverse events of continuous subcutaneous insulin infusion (CSII) with multiple daily …